Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;65(12):1948-56.
doi: 10.1007/s00018-008-8206-z.

Multiple phospholipase activation by OX(1) orexin/hypocretin receptors

Affiliations

Multiple phospholipase activation by OX(1) orexin/hypocretin receptors

L Johansson et al. Cell Mol Life Sci. 2008 Jun.

Abstract

We investigated coupling of OX(1) receptors to phospholipase activation and diacylglycerol generation in Chinese hamster ovary (CHO) cells using both biochemical and fluorescence "real-time" methods. The results indicate that at lowest orexin-A concentrations (highest potency), diacylglycerol generated results from phospholipase D activity. At 10-100-fold higher orexin-A concentrations, phospholipase C is activated, likely hydrolyzing phosphatidylinositol (PI) or phosphatidylinositol monophosphate (PIP) but not phosphatidylinositol bisphosphate (PIP(2)). At further 7-fold higher orexin-A concentrations, PIP(2) is hydrolyzed, releasing both diacylglycerol and inositol-1,4,5-trisphosphate. Thus, OX(1) orexin receptors connect to multiple phospholipase activities, apparently composed of at least one phospholipase D and two different phospholipase C activities. At low agonist concentrations, diacylglycerol and phosphatidic acid are the preferred products, and interestingly, it seems that even the primarily activated phospholipase C mainly works to increase diacylglycerol and not inositol-1,4,5-trisphosphate.

PubMed Disclaimer

Similar articles

Cited by

  • Orexin receptors in GtoPdb v.2021.3.
    Coleman P, de Lecea L, Gotter A, Hagan J, Hoyer D, Kilduff T, Kukkonen JP, Porter R, Renger J, Siegel JM, Sutcliffe G, Upton N, Winrow CJ. Coleman P, et al. IUPHAR BPS Guide Pharm CITE. 2021;2021(3):10.2218/gtopdb/f51/2021.3. doi: 10.2218/gtopdb/f51/2021.3. Epub 2021 Sep 2. IUPHAR BPS Guide Pharm CITE. 2021. PMID: 34927075 Free PMC article.
  • Brain orexin promotes obesity resistance.
    Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Kotz C, et al. Ann N Y Acad Sci. 2012 Aug;1264(1):72-86. doi: 10.1111/j.1749-6632.2012.06585.x. Epub 2012 Jul 17. Ann N Y Acad Sci. 2012. PMID: 22803681 Free PMC article. Review.
  • Role of orexin receptors in obesity: from cellular to behavioral evidence.
    Perez-Leighton CE, Butterick-Peterson TA, Billington CJ, Kotz CM. Perez-Leighton CE, et al. Int J Obes (Lond). 2013 Feb;37(2):167-74. doi: 10.1038/ijo.2012.30. Epub 2012 Mar 6. Int J Obes (Lond). 2013. PMID: 22391883 Free PMC article. Review.
  • Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine.
    Barr JL, Zhao P, Brailoiu GC, Brailoiu E. Barr JL, et al. Int J Mol Sci. 2021 May 13;22(10):5160. doi: 10.3390/ijms22105160. Int J Mol Sci. 2021. PMID: 34068146 Free PMC article.
  • Arachidonic acid release mediated by OX1 orexin receptors.
    Turunen PM, Ekholm ME, Somerharju P, Kukkonen JP. Turunen PM, et al. Br J Pharmacol. 2010 Jan;159(1):212-21. doi: 10.1111/j.1476-5381.2009.00535.x. Epub 2009 Dec 4. Br J Pharmacol. 2010. PMID: 20002100 Free PMC article.

Publication types

LinkOut - more resources